The global Flow Cytometry Market Size research report offers the definition, market shares, drivers, restraints, opportunities, and challenges in an voluminous format. On the basis of Type, the market is further categorized into based on the regions, the market is distributed into Asia Pacific, Europe, North America, Latin America, and the Middle East and Africa. This markets competitive manufactures and the upcoming manufactures are studied with their research. Revenue, production, price, market share of these players is mentioned with detailed information.
Flow Cytometry Market study
offers an exhaustive summary of the vendor landscape, competitive analysis, and
key strategies to gain ruthless advantage. Flow Cytometry Market Forecast
provides sizing and growth opportunities. It provides comprehensive insights on
the latest industry trends, forecast, and growth drivers in the market. it also
includes a detailed analysis of growth drivers, challenges, and investment
opportunities and delivers a complete overview of segments and the regional
outlook of the market.
Get Free PDF Sample (Including Full TOC,
List of Tables & Figures) @ https://www.millioninsights.com/industry-reports/flow-cytometry-market/request-sample
Industry Insights
The global flow cytometry
market size was estimated at USD 3.27 billion in 2016 and is anticipated to
grow at CAGR of 10.6% in coming years. Key drivers of this market include
increasing incidence of chronic disorders that requires toxicity testing for
cancer tests and need for quick, accurate and sensitive prognosis techniques
for the validation of disease.
Increasing awareness levels
amongst healthcare experts and patients coupled with rising healthcare
expenditures are major factors driving the growth. Furthermore, related
benefits of cell-based assays including development in reagents and software
employed for the study, ease-of-use and high sensitivity and reproductively are
some other elements anticipated to boost the growth in coming years.
Technology Insights
Cell-based technology held
the leading position in 2016. Rising demand for advance diagnosis and
increasing awareness related to related advantages with cell-based analysis are
the elements contributing to its leading position during the coming years.
Cell-based flow cytometry
involves substantial usage in variety of research fields. This analysis is
applied in the discovery of drug for physiological importance of results. Furthermore,
it is utilized in clinical studies involving endothelial cells in blood,
hematopoietic progenitor cells, and tumor cells in peripheral blood and tumour
stem cells. In addition, they are utilized in the study for target
identification and disease mechanism.
Application Insights
This technology is used in
industrial sectors, research and clinical diagnosis. Research segment held
leading position in 2016 due to increasing R&D for cancer and other
infectious diseases diagnosis and treatment. Flow cytometry has applications
even in some other industries including plant tissue culture and food
microbiology.
Clinical diagnosis is
anticipated to be the fastest growing application segment by the year 2025.
This growth is boosted by elements such as rising demand for cost-effective
disease diagnostic tools and related advantages of these assays in disease
detection.
End-use Insights
The commercial organization
segment dominated the industry due to extensive applications in various
verticals including plant cell culture, food microbiology and blood banks. The
entry of reagents and multiplex probes for definite usage in diagnostics and
discovery of drug is anticipated to benefit this vertical accompanied with
development opportunities by offering the users in research and small- scale
peripheral laboratories.
Hospitals are anticipated
to grow at remunerative CAGR owing to rising number of diagnostic tests
required by increasing prevalence of infectious and chronic diseases,
beneficial and supportive reimbursement policies and rising awareness among
patients.
Regional Insights
North America held leading
position in 2016 owing to the availability of solicitous government initiatives
for the growth of enhanced technologies pertaining to molecular diagnostics. Furthermore,
presence of skilled experts and larger awareness levels are the other factors
expected to drive the growth in regional market.
Asia Pacific is speculated
to demonstrate lucrative growth over the forecast period due to rising solicitous
government aid for the biotech industry growth. The economic development,
increasing patient awareness level, persistently advancing healthcare
infrastructure and presence of untapped opportunities are the factors
contributing towards the fast growth in this region.
Table of Contents:-
Chapter
1 Methodology and Scope
Chapter
2 Executive Summary
Chapter
3 Flow Cytometry: Market Variables, Trends & Scope
Chapter
4 Flow Cytometry: Product Estimates & Trend Analysis
Chapter
5 Flow Cytometry: Application Estimates & Trend Analysis
Chapter
6 Flow Cytometry: End-use Estimates & Trend Analysis
Chapter
7 Flow Cytometry: Industrial End-use Estimates & Trend Analysis
Chapter
8 Flow Cytometry: Regional Estimates & Trend Analysis
Chapter
9 Competitive Landscape
Chapter
10 Flow Cytometry: Manufacturers Company Profiles
Top Key Players of Flow
Cytometry Market:
Agilent Technologies;
Apogee Flow Systems Ltd.; Becton, Dickinson and Company; Beckman Coulter, Inc.;
Bio-Rad Laboratories, Inc.; GE Healthcare; Luminex Corporation; Merck &
Co., Inc., Miltenyi Biotec; Stratedigm, Inc.; Sysmex Corporation and Thermo
Fisher Scientific.
Know More Insights
@ https://newsonmarketblog.wordpress.com
No comments:
Post a Comment